Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
30.09.23
/
50%
€10.70
Target price
30.09.24
-
Performance (%)
17.76%
Price
20.05.24
€11.00
Summary
This prediction is currently active. The SELL prediction by StockNews_com currently has a performance of 17.76%. This prediction currently runs until 30.09.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Enanta Pharmaceuticals Inc. | -5.983% | -5.983% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.20
06.04.24
06.04.24
-
06.04.25
06.04.25
-17.11%
20.05.24
20.05.24
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.00
02.09.23
02.09.23
-
02.09.24
02.09.24
-15.38%
20.05.24
20.05.24